Sitafol Min Tablet 50/1000 mg

Adult dose

This drug is generally taken twice a day with food, and the dosage is gradually increased to minimize gastrointestinal adverse reactions from metformin. 1. For patients not receiving metformin treatment: This drug 50/500 mg is taken as 1 tablet twice a day, and it can be increased to 50/1000 mg taken as 1 tablet twice a day. 2. For patients already on metformin treatment: Sitagliptin

This drug is a diabetes treatment that contains sitagliptin and metformin, which helps to control blood sugar. Serious allergic reactions may occur during the use of this drug, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck appear, stop taking the medication immediately and consult a doctor. Additionally, this drug may cause pancreatitis, which is inflammation of the pancreas, so if symptoms such as sudden abdominal pain, vomiting, or fever occur after taking this drug, seek medical attention immediately. Patients with impaired kidney function, severe heart disease, severe liver disease, dehydration, or severe infections should not use this drug, and especially those with weakened kidney function should regularly undergo kidney function tests. This drug may cause lactic acidosis, which is a rare but life-threatening metabolic disorder, therefore, be aware of nonspecific symptoms such as muscle pain, difficulty breathing, fatigue, or abdominal pain, and if such symptoms occur, stop taking the medication immediately and seek medical treatment. It is advisable to avoid alcohol consumption while using this drug, and temporarily stop taking it if you are undergoing surgery or unable to consume food due to severe illness. There is a risk of hypoglycemia, so especially when taken with insulin or other antidiabetic agents, blood sugar levels should be checked frequently, and symptoms of hypoglycemia should be monitored closely. Pregnant women or women who may become pregnant and breastfeeding mothers should not take this drug. The safety and efficacy of this drug in children and adolescents under 18 years of age have not been sufficiently confirmed, so it is not used in these groups. During the course of taking this drug, it is important to have regular blood tests and kidney function tests to monitor for any adverse reactions. Finally, this drug may interact with other medications, so if you are taking other drugs, be sure to inform your doctor or pharmacist, particularly when taken with medications that may affect kidney function.

Serious side effects

Hives, angioedema, anaphylaxis, rash, Stevens-Johnson syndrome, exfoliative skin disease, acute pancreatitis, severe lactic acidosis, hypoglycemia (including loss of consciousness and seizures), difficulty breathing, acute renal failure, acute myocardial infarction, cardiovascular collapse, blistering pemphigoid, severe and debilitating joint pain, liver dysfunction (elevated liver enzymes, potential jaundice), severe neurological symptoms (such as headache, altered consciousness, seizures), severe edema

Mild side effects

• Diarrhea
• nausea
• vomiting
• abdominal pain
• upper respiratory infection
• nasopharyngitis
• headache
• hypoglycemia
• muscle pain
• limb pain

This drug should be stored in a sealed container to prevent air or moisture from entering, and it is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the drug's effectiveness.

Appearance

Red oval film-coated tablets

Package unit

PTP - 30 tablets/box [(10 tablets/PTP x 3)]